Contract facts
FederalNo full NAICS 325412 intel page yet. Browse NAICS intelligence
RADIOPHARMACEUTICALS MAMC is a federal award for W40m Mrco Pacific held by Jubilant Draximage Radiopharmacies, Inc. Estimated value $157K ($157K obligated). Current period of performance ends Jan 30, 2027. Place of performance: JOINT BASE LEWIS MCCHORD WA.
Recompete timing
PublicCurrent PoP ends Jan 30, 2027 (162 days remaining). Agencies typically plan 12–18 months ahead — at 5.3 months out, that window is already open. The buying decision is likely already in motion.
Incumbent footprint
Public recordJubilant Draximage Radiopharmacies, Inc — $14.3M obligated across 85 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract W81K0226FA029?
W81K0226FA029 (Radiopharmaceuticals MAMC) is a W40m Mrco Pacific award with a potential value of $157K, currently held by Jubilant Draximage Radiopharmacies, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded W81K0226FA029?
W40m Mrco Pacific awarded W81K0226FA029 to Jubilant Draximage Radiopharmacies, Inc (potential $157K).
Who is the incumbent on W81K0226FA029?
Jubilant Draximage Radiopharmacies, Inc is the incumbent with $14.3M across 85 related awards in SCOUT’s public footprint. The current period of performance ends Jan 30, 2027.
When does Jubilant Draximage Radiopharmacies, Inc’s W81K0226FA029 come up for recompete?
SCOUT tracks a period-of-performance end of Jan 30, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.